| Literature DB >> 25317861 |
Mansueto Gomes-Neto1, Erenaldo Sousa Rodrigues1, Walderi Monteiro Silva2, Vitor Oliveira Carvalho2.
Abstract
The use of yoga as an effective cardiac rehabilitation in patients with chronic heart failure (CHF) remains controversial. We performed a meta-analysis to examine the effects of yoga on exercise capacity and health-related quality of life (HRQOL) in patients with CHF.Entities:
Year: 2014 PMID: 25317861 PMCID: PMC4262105 DOI: 10.5935/abc.20140149
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Search strategy for MEDLINE via PubMed for yoga and heart failure trials
| 1. | Randomized controlled trials/ |
| 2. | Random allocation/ |
| 3. | Controlled clinical Trials/ |
| 4. | Control groups/ |
| 5. | Clinical trials OR clinical trials, phase I OR clinical trials, phase II OR clinical trials, phase III OR clinical trials, phase IV/ |
| 6. | Clinical trials data monitoring committees/ |
| 7. | Double-blind method/ |
| 8. | Single-blind method/ |
| 9. | Placebos/ |
| 10. | Placebo effect/ |
| 11. | Cross-over studies/ |
| 12. | Multicenter Studies/ |
| 13. | 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 |
| 14. | Heart failure/ |
| 15. | Cardiomyopathy, dilated/ |
| 16. | Heart failure, diastolic/ |
| 17. | Heart failure, systolic |
| 18. | Cardiac output, low/ |
| 19. | 14 OR 15 OR 16 OR 17 OR 18 |
| 20. | Yoga |
| 21. | Yogic/ |
| 22. | Asana/ |
| 23. | Pranayama/ |
| 24. | 20 OR 21 OR 22 OR 23 |
| 25. | 13 AND 19 AND 24 |
Figure 1Search and selection of studies for systematic review according PRISMA.
Study quality on the PEDro scale
| 1 | Pullen et al[ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | ||||
| 2 | Pullen et al[ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 |
1: eligibility criteria and source of participants; 2: random allocation; 3: concealed allocation; 4: baseline comparability; 5: blinded participants; 6: blinded therapists; 7: blind assessors; 8: adequate follow-up; 9: intention-to-treat analysis; 10: between-group comparisons; and 11: point estimates and variability.
*Item 1 does not contribute to the total score.
Characteristics of the outcomes, measures, and results of yoga therapy in the trials included in the review
| Aerobic capacity | HRQOL | Aerobic capacity | HRQOL | ||||
| 1 | Pullen et al[ | 130 CHF NYHA I, II, and III | Aerobic capacity HRQOL | Graded exercise testing | Minnesota LHFQ | ↑ VO2 peak | ↑ HRQOL |
| 2 | Pullen et al[ | 51 CHF NYHA I, II, and III | Aerobic capacity HRQOL | Graded exercise stress test | Minnesota LHFQ | ↑ VO2 peak | ↑HRQOL |
CHF: Chronic Heart Failure; NYHA: New York Heart Association; MHFLQ: Minnesota Living with Heart Failure Questionnaire; HRQQL: Health-related quality of life.
Figure 2Yoga versus controls: VO2 Peak. Review Manager (version 5.2; the Cochrane Collaboration, 2013). SD: standard deviation; CI = Confidence intervals
Figure 3Yoga versus controls: Quality of Life. Review Manager (version 5.2; the Cochrane Collaboration, 2013). SD: standard deviation; CI: Confidence intervals.